Munich, Germany

Lars Friedrich

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lars Friedrich: Innovator in Protein Modification

Introduction

Lars Friedrich is a notable inventor based in Munich, Germany. He has made significant contributions to the field of protein modification, particularly through his innovative patents. With a total of two patents to his name, Friedrich's work has the potential to impact various applications in biotechnology and medicine.

Latest Patents

Friedrich's latest patents focus on a modified form of L-asparaginase. The first patent discloses a modified protein that combines an L-asparaginase with one or more (poly)peptides. These (poly)peptides consist solely of proline and alanine amino acid residues. The methods of preparation and use of this modified protein are also detailed in the patent. This innovation could lead to advancements in therapeutic applications, particularly in treating certain types of cancer.

Career Highlights

Throughout his career, Lars Friedrich has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Jazz Pharmaceuticals and Xl-Protein GmbH. His experience in these organizations has contributed to his expertise in protein engineering and modification.

Collaborations

Friedrich has collaborated with various professionals in his field, including Anne O'Donnell. These partnerships have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Lars Friedrich is a distinguished inventor whose work in protein modification has the potential to influence the biotechnology industry significantly. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…